Pages that link to "Q28085699"
Jump to navigation
Jump to search
The following pages link to Methylation of cell-free circulating DNA in the diagnosis of cancer (Q28085699):
Displaying 50 items.
- Cell-free circulating tumor DNA in cancer (Q26750899) (← links)
- Methylated circulating tumor DNA in blood: power in cancer prognosis and response (Q26772077) (← links)
- DNA methylation changes in epithelial ovarian cancer histotypes (Q27690722) (← links)
- Epigenetics in diagnosis of colorectal cancer (Q28071714) (← links)
- Cell-free DNA as a diagnostic marker for cancer: current insights (Q28074556) (← links)
- Integrating Epigenomics into the Understanding of Biomedical Insight (Q28077579) (← links)
- Methylation-sensitive enrichment of minor DNA alleles using a double-strand DNA-specific nuclease (Q33557917) (← links)
- Cell-free and intracellular nucleic acids: new non-invasive biomarkers to explore male infertility (Q33587517) (← links)
- RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA. (Q33591552) (← links)
- Gene methylation as a powerful biomarker for detection and screening of non-small cell lung cancer in blood (Q33761873) (← links)
- Biomarker discovery: quantification of microRNAs and other small non-coding RNAs using next generation sequencing (Q35679243) (← links)
- Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review (Q36277022) (← links)
- Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma. (Q36443927) (← links)
- Identification of tissue-specific cell death using methylation patterns of circulating DNA (Q36770646) (← links)
- Aberrant methylation of PCDH10 and RASSF1A genes in blood samples for non-invasive diagnosis and prognostic assessment of gastric cancer (Q37001109) (← links)
- Cancer Biomarkers from Genome-Scale DNA Methylation: Comparison of Evolutionary and Semantic Analysis Methods (Q37200842) (← links)
- Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer. (Q37306747) (← links)
- Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract. (Q37497846) (← links)
- Silencing of cZNF292 circular RNA suppresses human glioma tube formation via the Wnt/β-catenin signaling pathway (Q37665353) (← links)
- The role of cell-free DNA in predicting colorectal cancer prognosis (Q38637642) (← links)
- LINE-1 Hypermethylation in Serum Cell-Free DNA of Relapsing Remitting Multiple Sclerosis Patients. (Q38679773) (← links)
- Lung cancer screening: utility of molecular applications in conjunction with low-dose computed tomography guidelines (Q38718638) (← links)
- A 2015 survey of established or potential epigenetic biomarkers for the accurate detection of human cancers (Q38777365) (← links)
- The role of ctDNA detection and the potential of the liquid biopsy for breast cancer monitoring (Q38825179) (← links)
- Precancer Atlas to Drive Precision Prevention Trials. (Q38857539) (← links)
- Towards DNA methylation detection using biosensors (Q38972400) (← links)
- Current and Emerging Technologies for the Analysis of the Genome-Wide and Locus-Specific DNA Methylation Patterns (Q39003554) (← links)
- Platelets, circulating tumor cells, and the circulome. (Q39408199) (← links)
- An epigenetic signature of adhesion molecules predicts poor prognosis of ovarian cancer patients (Q41593205) (← links)
- DNA Methylation as a Noninvasive Epigenetic Biomarker for the Detection of Cancer (Q42361143) (← links)
- The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review (Q42643973) (← links)
- Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients (Q47152528) (← links)
- Liquid biopsy in non-small cell lung cancer: a key role in the future of personalized medicine? (Q47883536) (← links)
- Epigenetic regulation by DNA methylation and miRNA molecules in cancer. (Q47915829) (← links)
- Emerging Biomarkers in Cutaneous Melanoma. (Q48092515) (← links)
- Evaluation of Streck BCT and PAXgene Stabilised Blood Collection Tubes for Cell-Free Circulating DNA Studies in Plasma. (Q48253205) (← links)
- DNA Methylation Analysis from Body Fluids (Q50182604) (← links)
- Depletion of enteroendocrine and mucus-secreting cells is associated with colorectal carcinogenesis severity and impaired intestinal motility in rats. (Q51001933) (← links)
- Analysis of RTEL1 and PCDHGB6 promoter methylation in circulating-free DNA of lung cancer patients using liquid biopsy: A pilot study. (Q51477838) (← links)
- Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients. (Q52944557) (← links)
- The Clinical Utility of Cell-Free DNA Measurement in Differentiated Thyroid Cancer: A Systematic Review. (Q55101444) (← links)
- Importance of Cadherins Methylation in Ovarian Cancer: a Next Generation Sequencing Approach (Q58111952) (← links)
- Cell-free DNA in cancer: current insights (Q58113203) (← links)
- Highly sensitive detection of DNA hypermethylation in melanoma cancer cells (Q58569334) (← links)
- Cell-Free DNA Methylation of Selected Genes Allows for Early Detection of the Major Cancers in Women (Q58693501) (← links)
- Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy (Q61799424) (← links)
- Lung Cancer Screening, Towards a Multidimensional Approach: Why and How? (Q62490647) (← links)
- Pancreatic Cancer Heterogeneity Can Be Explained Beyond the Genome (Q64071959) (← links)
- Disease prediction by cell-free DNA methylation (Q88408823) (← links)
- Analysis of Syndecan-2 Methylation in Bowel Lavage Fluid for the Detection of Colorectal Neoplasm (Q88581394) (← links)